Search

HyPro3 - Hydergine

$89 USD

HyPro3 is a research compound containing 2.25mg per capsule of ergot alkaloids, including dihydroergocornine, dihydroergocristine, and dihydroergocryptine. Produced in a GMP and ISO-compliant facility, this formula is designed for research use and aims to provide consistent quality for scientific studies. Each bottle contains 60 capsules, made in the EU.

 

  • 60 x 2.25mg Capsules
  • Formula: C19H23N3O2
  • Trade name: Ergoloid
  • 3.5-hour half-life
  • Produced in a GMP and ISO compliant facility
Availability: In stock
+ -

What is HyPro3?

HyPro3 is a research-grade compound containing Hydergine, a blend of dihydroergocornine, dihydroergocristine, and dihydroergocryptine. Hydergine has been studied for its involvement in cellular processes related to circulation and oxygenation, although more research is needed to explore these effects fully. HyPro3 comes in a bottle of 60 capsules, with each capsule containing 2.25mg of Hydergine, making it ideal for ongoing research studies.

This product is intended for cognitive research purposes and is not sold for human consumption or therapeutic use.

Key Features

  • 60 Capsules
  • Produced for research purposes
  • 2-3 week delivery to most countries
  • Minimal excipients

Product Information

Unit sizeNot applicable (research purposes)
Units per container60 capsules
Amount per unitHydergine (dihydroergocornine, dihydroergocristine, dihydroergocryptine) 2.25mg
Other ingredientsMicrocrystalline cellulose (filler), vegetarian capsule

How it Works

Hydergine, the active ingredient in HyPro3, has been studied for its potential involvement in oxygenation and cellular functions, though further research is needed to confirm these findings. Its mechanisms are primarily explored in scientific studies, with no therapeutic claims made for this product [1].

Storage Instructions

Store HyPro3 in a cool, dry place away from direct sunlight to maintain product integrity. Ensure the container is sealed to protect the capsules from moisture and contamination.

Legality and Regulatory Information

Hydergine is regulated as a prescription compound in several countries, including the United States. In the European Union and Australia, regulations may vary. Please check local guidelines before purchasing or using HyPro3 for research purposes.

Packaging and Presentation

HyPro3 is supplied in a bottle of 60 capsules, designed for easy handling in laboratory environments. The capsules are vegetarian and formulated with minimal excipients for quality and consistency in research settings.

Is HyPro3 Suitable for Your Research?

If your research involves studying compounds related to cellular oxygenation and other processes, HyPro3 may be suitable for your needs. Ensure that all research is conducted following appropriate guidelines and protocols.

Frequently Asked Questions (FAQs)

Q: Can HyPro3 be combined with other research compounds?

A: While combining compounds in research is common, it is essential to consider potential interactions. Always consult available studies and protocols before proceeding.

Q: What are the storage requirements for HyPro3?

A: Store HyPro3 in a cool, dry place, away from direct sunlight and moisture. Ensure the bottle is tightly sealed to maintain product stability.

Q: Is HyPro3 legal in my country?

A: The legal status of Hydergine varies by country. In some regions, such as the U.S., it requires a prescription. Always verify local laws before acquiring HyPro3 for research purposes.

References

  • [1] Malík M, Tlustoš P. Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs. Nutrients. 2022 Aug 17;14(16):3367. doi: 10.3390/nu14163367. PMID: 36014874; PMCID: PMC9415189. Study Reference.
  • [2] Li X, Wen W, Li P, Fu Y, Chen H, Wang F, Dai Y, Xu S. Mitochondrial Protection and Against Glutamate Neurotoxicity via Shh/Ptch1 Signaling Pathway to Ameliorate Cognitive Dysfunction by Kaixin San in Multi-Infarct Dementia Rats. Oxid Med Cell Longev. 2021 Jul 9;2021:5590745. doi: 10.1155/2021/5590745. PMID: 34306310; PMCID: PMC8285175. Study Reference.
  • [3] Andrade C, Radhakrishnan R. The prevention and treatment of cognitive decline and dementia: An overview of recent research on experimental treatments. Indian J Psychiatry. 2009 Jan;51(1):12-25. doi: 10.4103/0019-5545.44900. PMID: 19742190; PMCID: PMC2738400. Study Reference.

Disclaimer

This product is intended for research purposes only and is not sold for human consumption. It is not intended to diagnose, treat, cure, or prevent any disease. The information provided here is for educational purposes and does not constitute medical advice.

Shipping OptionsInternational Mail Tracked (10-14 Business Days)
Economy Mail Untracked (14-25 Business Days)
Ships FromSingapore
Ships ToWorldwide shipping is available
TrackingYes
Write your own review Close Review Form
  • Only registered users can write reviews
*
*
  • Bad
  • Excellent
Description
Customers who bought this item also bought